Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Assets Average (2016 - 2025)

Historic Assets Average for Regenxbio (RGNX) over the last 11 years, with Q3 2025 value amounting to $553.1 million.

  • Regenxbio's Assets Average rose 162.95% to $553.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $553.1 million, marking a year-over-year increase of 162.95%. This contributed to the annual value of $520.0 million for FY2024, which is 2609.93% down from last year.
  • Per Regenxbio's latest filing, its Assets Average stood at $553.1 million for Q3 2025, which was up 162.95% from $536.0 million recorded in Q2 2025.
  • Regenxbio's 5-year Assets Average high stood at $1.1 billion for Q1 2022, and its period low was $478.5 million during Q1 2025.
  • For the 5-year period, Regenxbio's Assets Average averaged around $728.2 million, with its median value being $715.1 million (2023).
  • Per our database at Business Quant, Regenxbio's Assets Average skyrocketed by 8779.61% in 2021 and then crashed by 2966.14% in 2023.
  • Quarter analysis of 5 years shows Regenxbio's Assets Average stood at $957.1 million in 2021, then fell by 10.3% to $858.5 million in 2022, then fell by 29.66% to $603.9 million in 2023, then dropped by 18.44% to $492.6 million in 2024, then increased by 12.3% to $553.1 million in 2025.
  • Its last three reported values are $553.1 million in Q3 2025, $536.0 million for Q2 2025, and $478.5 million during Q1 2025.